Curaleaf management commentary attributes narrower Q3 2026 net loss from continuing operations to lower tax provision
Bitget2026/11/04 02:58- Curaleaf management commentary attributed third-quarter 2026 revenue growth of 11% to USD 352.65 million to retail expansion and stronger wholesale distribution.
- International revenue rose 28% to USD 58.7 million, driven by patient growth and flower and vape sales in Germany and Britain.
- Gross margin fell to 48% from 51%, reflecting changes in product mix, including the balance of wholesale versus retail sales.
- Operating expenses increased 9% to USD 167.53 million, primarily reflecting higher compensation costs and professional fees.
- Net loss narrowed to USD 32.72 million from USD 56.68 million, primarily reflecting a lower tax provision and improved discontinued operations.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bank of Japan minutes turn hawkish: Most members believe a rate hike is needed soon, with a 70% probability of a hike in December
Minutes from the Bank of Japan show that several members believe a rate hike is needed in the near term, with a roughly 70% probability of an increase in December. Core inflation has met the target for the first time in 30 years, and the current policy rate stands at 1.25%.
Former Chainlink Product Marketing Director Michael Robinson joins Monad Foundation
The Federal Reserve Eyes $1.8 Trillion in “Shadow Credit”: Dallas and New York Fed Launch First Private Credit Survey
The Dallas and New York Federal Reserves have launched an investigation into private credit lending standards, covering an industry worth 1.8 trillions USD, with a minimum threshold of 50 millions USD. The results will be released in the first quarter of 2027.
Tom Lee Says a VIX Signal Points to a Stock Market Bottom
Crypto prices
More
